Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Olba Healthcare Holdings's annualized net income for the quarter that ended in Dec. 2025 was 円0 Mil. Olba Healthcare Holdings's average shareholder tangible equity for the quarter that ended in Dec. 2025 was 円11,359 Mil. Therefore, Olba Healthcare Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 0.00%.
The historical rank and industry rank for Olba Healthcare Holdings's Return-on-Tangible-Equity or its related term are showing as below:
TSE:2689'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 5.01 Med: 14.29 Max: 19.54
Current: 7.74
During the past 13 years, Olba Healthcare Holdings's highest Return-on-Tangible-Equity was 19.54%. The lowest was 5.01%. And the median was 14.29%.
TSE:2689's Return-on-Tangible-Equity is ranked worse than 55.86% of 111
companies
in the Medical Distribution industry
Industry Median: 8.78
vs TSE:2689: 7.74
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Olba Healthcare Holdings Return-on-Tangible-Equity Related Terms
Olba Healthcare Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Olba Healthcare Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2689 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Olba Healthcare Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba Healthcare Holdings Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba Healthcare Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Olba Healthcare Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Olba Healthcare Holdings (TSE:2689) has a Return-on-Tangible-Equity of 0.00% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Olba Healthcare Holdings and its competitors. Over the past decade, Olba Healthcare Holdings' Return-on-Tangible-Equity has ranged from 5.01 to 19.54. According to the industry distribution chart, Olba Healthcare Holdings ranks #62 out of 111 companies in the Medical Distribution industry, placing it in the top 55.9%.
Is Olba Healthcare Holdings' Return-on-Tangible-Equity too high?
Olba Healthcare Holdings' current Return-on-Tangible-Equity is 0.00%. Over the past 10 years, this metric has ranged from a low of 5.01 to a high of 19.54. Based on the distribution chart, Olba Healthcare Holdings ranks #62 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Olba Healthcare Holdings has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Olba Healthcare Holdings' Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba Healthcare Holdings ranks #62 out of 111 companies for Return-on-Tangible-Equity. This places Olba Healthcare Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.78. Historically, Olba Healthcare Holdings' own Return-on-Tangible-Equity has ranged from 5.01 to 19.54 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.78, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Olba Healthcare Holdings and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba Healthcare Holdings's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Olba Healthcare Holdings (TSE:2689) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,619.26, compared to a current price of 円1,901.00 — trading 17.4% above its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Olba Healthcare Holdings' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Olba Healthcare Holdings (TSE:2689), the current Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba Healthcare Holdings (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba Healthcare Holdings stock appears to be overvalued.
The current stock price of 円1,901.00 is trading 17.4% above its estimated GF Value™ of 円1,619.26.
GuruFocus considers Olba Healthcare Holdings to be Modestly Overvalued.
Key valuation signals for TSE:2689:
Return-on-Tangible-Equity: 0.00%
GF Value™: 円1,619.26 vs. price of 円1,901.00 (17.4% above fair value)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
63GF Score
Get the complete analysis for TSE:2689
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
